Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP502496.RAe9qKLdpy2U6VMhfBLdIGfJ9z3zTkTlyqSGNe4J-HZCM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502496.RAe9qKLdpy2U6VMhfBLdIGfJ9z3zTkTlyqSGNe4J-HZCM130_assertion type Assertion NP502496.RAe9qKLdpy2U6VMhfBLdIGfJ9z3zTkTlyqSGNe4J-HZCM130_head.
- NP502496.RAe9qKLdpy2U6VMhfBLdIGfJ9z3zTkTlyqSGNe4J-HZCM130_assertion description "[MET would be an important therapeutic antitumor target to be inhibited, and in lung cancer, MET may represent a cancer early progenitor cell marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502496.RAe9qKLdpy2U6VMhfBLdIGfJ9z3zTkTlyqSGNe4J-HZCM130_provenance.
- NP502496.RAe9qKLdpy2U6VMhfBLdIGfJ9z3zTkTlyqSGNe4J-HZCM130_assertion evidence source_evidence_literature NP502496.RAe9qKLdpy2U6VMhfBLdIGfJ9z3zTkTlyqSGNe4J-HZCM130_provenance.
- NP502496.RAe9qKLdpy2U6VMhfBLdIGfJ9z3zTkTlyqSGNe4J-HZCM130_assertion SIO_000772 18709663 NP502496.RAe9qKLdpy2U6VMhfBLdIGfJ9z3zTkTlyqSGNe4J-HZCM130_provenance.
- NP502496.RAe9qKLdpy2U6VMhfBLdIGfJ9z3zTkTlyqSGNe4J-HZCM130_assertion wasDerivedFrom befree-20140225 NP502496.RAe9qKLdpy2U6VMhfBLdIGfJ9z3zTkTlyqSGNe4J-HZCM130_provenance.
- NP502496.RAe9qKLdpy2U6VMhfBLdIGfJ9z3zTkTlyqSGNe4J-HZCM130_assertion wasGeneratedBy ECO_0000203 NP502496.RAe9qKLdpy2U6VMhfBLdIGfJ9z3zTkTlyqSGNe4J-HZCM130_provenance.